# Clinical Study on the Efficacy and Safety of BAT5906 Injection

> **NCT05141994** · PHASE2 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 48 (actual)

## Conditions studied

- Wet Age-related Macular Degeneration

## Interventions

- **DRUG:** 2.5mg of BAT5906
- **DRUG:** 4mg of BAT5906

## Key facts

- **NCT ID:** NCT05141994
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-26
- **Primary completion:** 2022-09-06
- **Final completion:** 2022-09-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141994, "Clinical Study on the Efficacy and Safety of BAT5906 Injection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05141994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*